Loading
Total declarations
Companies
▲ Purchases (16 ops.)
▼ Sales (3 ops.)
Latest filing published 27 Apr 2023 for Provention Bio, Inc..
Filing timeline
BuySaleAshleigh Palmer
Insider track record
Disclosed buys
16
Disclosed sells
3
Signal history
Closed purchases
Market purchases
16
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ashleigh Palmer: trading record in brief
Ashleigh Palmer (chief executive) discloses dealings in 2 companies, chiefly Provention Bio, Inc. and Unigene Laboratories Inc. In total, 23 filings cover trades dated from 18 June 2010 to 27 April 2023.
Market trades split into 16 purchases (€396k) and 3 sales (€943k). On balance, insiders were net sellers of €547k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 option exercises. Since January 2023: no purchases and 3 sales on the market.
Half of the purchases are above €11k and half below. Of 10 purchases, 9 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 27 April 2023, reports a transaction in Provention Bio, Inc. The latest purchase dates back some time: it was published 1,790 days ago, on 1 December 2021. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ashleigh Palmer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
2,570,050 sharesCommon StockSEC:0001493152-23-013916:0
50,000 shares@ US$10.1130.5% of flowCommon StockSEC:0001493152-23-005076:1
25,835 shares@ US$2.503.9% of flowCommon StockSEC:0001493152-23-005076:2
25,835 shares@ US$10.0415.8% of flowCommon StockSEC:0001493152-23-005076:3
50,000 shares@ US$2.5059.8% of flowCommon StockSEC:0001493152-23-005076:0
24,165 shares@ US$10.2714.9% of flowCommon StockSEC:0001493152-23-002086:1
24,165 shares@ US$2.5028.8% of flowCommon StockSEC:0001493152-23-002086:0
3,750 shares@ US$6.66411.4% of flowCommon StockSEC:0001493152-21-030245:0
Canonical exit: 28 Feb 2022 (T+90)
500 shares@ US$12.692.3% of flowCommon StockSEC:0001493152-20-016236:0
Canonical exit: 16 Nov 2020 (T+90)
2,800 shares@ US$12.8313.2% of flowCommon StockSEC:0001493152-20-016129:0
Canonical exit: 15 Nov 2020 (T+90)
2,075 shares@ US$11.394.0% of flowCommon StockSEC:0001493152-19-019631:0
Canonical exit: 19 Mar 2020 (T+90)
3,000 shares@ US$8.384.3% of flowCommon StockSEC:0001493152-19-014517:0
Canonical exit: 23 Dec 2019 (T+90)
10,600 shares@ US$9.1516.1% of flowCommon StockSEC:0001493152-19-011938:0
Canonical exit: 6 Nov 2019 (T+90)
4,000 shares@ US$10.837.2% of flowCommon StockSEC:0001493152-19-009411:0
Canonical exit: 16 Sept 2019 (T+90)
5,000 shares@ US$1.731.4% of flowCommon StockSEC:0001493152-18-018148:0
Canonical exit: 28 Mar 2019 (T+90)
825 shares@ US$1.580.2% of flowCommon StockSEC:0001493152-18-018148:1
Canonical exit: 31 Mar 2019 (T+90)
37,500 shares@ US$4.0024.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001493152-18-010239:0
Canonical exit: 17 Oct 2018 (T+90)
2,500 shares@ US$0.525Common StockSEC:0001437749-11-009754:0
Canonical exit: 20 Mar 2012 (T+90)
7,500 shares@ US$0.53Common StockSEC:0001437749-11-009754:1
Canonical exit: 20 Mar 2012 (T+90)
8,800 shares@ US$0.70Common StockSEC:0001437749-10-003076:0
Canonical exit: 19 Dec 2010 (T+90)
20,000 shares@ US$0.60Common StockSEC:0001437749-10-002618:0
Canonical exit: 10 Nov 2010 (T+90)
2,500 shares@ US$0.77Common StockSEC:0001437749-10-001898:0
Canonical exit: 16 Sept 2010 (T+90)
18,700 shares@ US$0.80Common StockSEC:0001437749-10-001898:1
Canonical exit: 16 Sept 2010 (T+90)
23 of 23 declarations
